SEC Form 4 research
| Issuer | MADRIGAL PHARMACEUTICALS, INC. |
|---|---|
| Tickers | MDGL, SNTA |
| Reporting owners | 59 |
| Officers and directors | 31 |
| Last public filing | 2026-09-11 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 640 | $537.17 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 1,040 | $536.11 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 644 | $535.27 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 396 | $534.2 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 512 | $533.09 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 368 | $531.99 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 522 | $530.23 | Not reported |
| 2026-09-11 | 2026-09-11 | Sibold William John | S | 120 | $546.38 | Not reported |
| 2026-09-11 | 2026-09-11 | Sibold William John | S | 761 | $544.83 | Not reported |
| 2026-09-11 | 2026-09-11 | Sibold William John | S | 1,539 | $544.02 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.